GW Prescribed capsules CEO Justin Gover discusses how the firm secured FDA reputation of its cannabis-derived drug and what it says relating to the long flee of cannabis-derived capsules.
GW Pharma CEO on fresh cannabis-derived drug
Tweet on Twitter
Share on Facebook
Pinterest
